Mucous membrane pemphigoid

Dental Clinics of North America

Volumn 49, Issue 1 SPEC.ISS., 2005, Pages 91-106

  Sollecito, Thomas P ^a   Parisi, Ernesta ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE DIPROPIONATE; CLOBETASOL PROPIONATE; CORTICOSTEROID; DAPSONE; FLUOCINONIDE; MINOCYCLINE; MYCOPHENOLIC ACID; NICOTINAMIDE; TETRACYCLINE;

AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CORRELATION ANALYSIS; DATA ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; ERYTHEMA; FEVER; FLUSHING; HEMOLYSIS; HEMOLYTIC ANEMIA; HLA SYSTEM; HUMAN; HYPERSENSITIVITY; IMMUNOGENICITY; INCIDENCE; LIVER DYSFUNCTION; LIVER TOXICITY; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; METHEMOGLOBINEMIA; NONHUMAN; PATHOPHYSIOLOGY; PRURITUS; PUSTULE; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

EID: 9444285506     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2004.07.004     Document Type: Review

References (55)

1. M.S. Greenberg Ulcerative, vesicular, and bullous lesions M.S. Greenberg M. Glick Burket's oral medicine: diagnosis and treatment 10th edition 2003 B.C. Decker Philadelphia 73
2. K.N. Ciarrocca, and M.S. Greenberg A retrospective study of the management of oral mucous membrane pemphigoid with dapsone Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 1999 159 163
3. L.S. Chan, K.B. Yancey, C. Hammerberg, H.K. Soong, J.A. Regezi, and K. Johnson Immune-mediated subepithelial blistering diseases of mucous membranes: pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificities of autoantibodies Arch Dermatol 129 1993 448 455
4. C. Scully, M. Carozzo, S. Gandolfo, P. Puiatti, and R. Monteil Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity Oral Surg Oral Med Oral Pathol Endod 88 1999 56 68
5. P. Bernard, L. Vaillant, and B. Laibelle Incidence and distribution of sub-epidermal autoimmune bullous skin diseases in 3 French regions Arch Dermatol 131 1995 48 52
6. B.J. Mondino, and I.B. Stuart Ocular cicatricial pemphigoid Opthalmology 88 1981 95 100
7. T.E. Daniels, and C. Quadra-White Direct immunofluorescence in oral mucosal disease: a diagnostic analysis of 130 cases Oral Surg Oral Med Oral Pathol 51 1981 38 54
8. A.R. Ahmed, B.S. Kurgis, and R.S. Rogers Cicatricial pemphigoid J Am Acad Dermatol 24 1991 987 1001
9. T. Van Joost, and A.J. Van't Veen Drug-induced cicatricial pemphigoid and acquired epidermolysis bullosa Clin Dermatol 11 1993 521 527
10. G. Laskaris, and R.A. Satriano Drug-induced blistering oral lesions Clin Dermatol 11 1993 545 550
11. M. Nayar, F. Wojnarowska, V. Venning, and C.J. Taylor Association of autoimmunity and cicatricial pemphigoid: is there an immunogenetic basis? J Am Acad Dermatol 25 1991 1011 1015
12. J.C. Delgado, D. Turbay, and E.J. Yunis A common major histocompatibility complex class II allel HLA-DQB1*0301 is present in clinical variant of pemphigoid Proc Natl Acad Sci U S A 93 1996 8569 8571
13. V.A. Venning, P.A. Frith, and A.J. Bron Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study Br J Dermaol 118 1988 7
14. T.E. Fleming, and N.J. Korman Cicatricial pemphigoid J Am Acad Dermatol 43 2000 571 591
15. L.R. Eversole Immunopathology of oral mucosal ulcerative, desquamative and bullous diseases Oral Surg Oral Med Oral Pathol 77 1994 555 571
16. L.R. Eversole Adhesion molecules and oral mucosal diseases Oral Dis 2 1996 185 187
17. S. Dayan, R.K. Simmons, and A.R. Ahmed Contemporary issues in the diagnosis of oral pemphigoid: a selective review of the literature Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 1999 424 430
18. K.B. Yancey Adhesion molecules, II: interactions of keratinocytes with epidermal basement membrane J Invest Dermatol 104 1995 1008 1014
19. B.E. Symington, Y. Takada, and W.G. Carter Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: potential role in keratinocyte intercellular adhesion J Cell Biol 120 1993 523 535
20. R.E. Burgeson, M. Chiquet, R. Deutzmann, P. Ekblom, J. Engel, and H. Kleinman A new nomenclature for the laminins Matrix Biol 14 1994 209 211
21. M.S. Lin, J.M. Mascaro, Z. Liu, A. Espana, and L.A. Diaz The desmosome and hemidesmosome in cutaneous autoimmunity Clin Exp Immunol 107 Suppl 1 1997 9 15
22. E. Dabelsteen Molecular biological aspects of acquired bullous diseases Crit Rev Oral Biol Med 9 1998 162 178
23. C. Bedane, J.R. McMillan, S.D. Balding, P. Bernard, C. Prost, and J.M. Bonnetblanc Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP 180 ectodomainin: evidence that BP180 spans the lamina lucida J Inves Dermatol 108 1997 901 907
24. L.S. Chan, A.R. Ahmed, G.J. Anhalt, W. Bernauer, K.D. Cooper, and M.J. Elder The First International Consensus on Mucous Membrane Pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators Arch Dermatol 138 2002 370 379
25. J. Allen, V.A. Venning, and M. Nayar Immunofluorescence studies in cicatricial pemphigoid Br J Dermatol 125 1991 495 [Abstr.]
26. J. Setterfield, P.F. Shirlaw, B.S. Bhogal, K. Tilling, S.J. Challacombe, and M.M. Black Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity Br J Dermatol 140 1999 645 650
27. L.E. Gately, and L.T. Nesbitt Update on immunofluorescent testing in bullous diseases and lupus erythematosus Dermatol Clin 12 1994 133 142
28. Z. Lazarova, and K.B. Yancey Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin: specificity, sensitivity, and practical considerations J Am Acad Dermatol 35 1996 389 403
29. C.O. Egan, Z. Lazarova, T.N. Darling, C. Yee, and K.B. Yancey Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations Medicine 82 2003 177 186
30. V. Sivalingam, C.L. Shields, J.A. Shields, and J.D. Pearah Squamous cell carcinoma of the conjunctiva associated with benign mucous membrane pemphigoid Ann Ophthalmol 22 1990 106 109
31. G.E. Gibson, M.S. Daoud, and M.R. Pittelkow Anti-epiligrin (laminin-5) cicatricial pemphigoid and lung carcinoma: coincidence or association? Br J Dermatol 137 1997 780 782
32. J. Setterfield, P.J. Shirlaw, Z. Lazarova, B.M. Bryant, B.S. Bhogal, and K. Harman Paraneoplastic cicatricial pemphigoid Br J Dermatol 141 1999 127 131
33. P. Lenz, R. Hsu, C. Yee, K.B. Yancey, B. Volc-Platzer, and G. Stingl Cicatricial pemphigoid with autoantibodies to laminin-5 (epiligrin) in a patient with metastatic endometrial carcinoma Huatarzt 49 1998 31 35
34. K. Taniuchi, M. Takata, C. Matsui, Y. Fushida, K. Uchiyama, and T. Mori Antiepiligrin (laminin-5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin-5 Br J Dermatol 140 1999 696 700
35. W. Fujimoto, A. Ishida-Yamaoto, R. Hsu, Y. Nagao, H. Iizuka, and K.B. Yancey Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita Br J Dermatol 139 1998 682 687
36. K.M. Lish, K. Washenik, K.B. Yancey, C. Yee, and M.J. Rico Anti-epiligrin cicatricial pemphigoid in a patient with HIV J Am Acad Dermatol 36 3 Pt 1 1997 486 488
37. M. Leverkus, E. Schmidt, Z. Lazarova, E.B. Brocker, K.B. Yancey, and D. Zillikens Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? Arch Dermatol 135 1999 1091 1098
38. K.B. Yancey, and C.A. Egan Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations JAMA 284 2000 350 356
39. A.J. Kettle, and C.C. Winterbourne Superoxide is an antagonist of anti-inflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase Biochem Pharmacol 45 1993 2003 2010
40. J.M. Van Zyl, K. Basson, A. Kriegler, and B.J. van der Walt Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties Biochem Pharmacol 42 1991 599 608
41. M.D. Coleman Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance Br J Dermatol 129 1993 507 513
42. S.M. Debol, M.J. Herron, and R.D. Nelson Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction J Leukoc Biol 62 1997 827 836
43. R.P. Hall Dermatitis herpetiformis J Invest Dermatol 99 1992 873 881
44. F. Hernandez, M. Linares, P. Colomina, E. Pastor, A. Cervero, and A. Perez Dapsone for refractory chronic idiopathic thrombocytopenic purpura Br J Haematol 90 1995 473 475
45. W. Nurnberg, J. Grabbe, and B.M. Czarnetzki Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline Acta Derm Venereol 75 1995 54 56
46. R.S. Rogers III, and D.A. Mehregan Dapsone therapy of cicatricial pemphigoid Semin Dermatol 7 1988 201 205
47. P. Todd, I.R. Samaratunga, and A. Pembroke Screening for glucose-6-phosphate dehydrogenase deficiency prior to dapsone therapy Clin Exp Dermaol 19 1994 217 218
48. L.E. Rhodes, M.D. Tingle, B.K. Park, P. Chu, J.L. Verbov, and P.S. Friedmann Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy Br J Dermatol 132 1995 257 262
49. J.W. Kelly, J. Scott, M. Sandland, M.B. Van der Weyeden, and R. Marks Vitamin E and dapsone-induced hemolysis Arch Dermatol 120 1984 1582 1584
50. R. Prussick, and N.H. Shear Dapsone hypersensitivity syndrome J Am Acad Dermatol 35 2 Pt 2 1996 346 349
51. L. Poskitt, and F. Wojnarowska Minimizing cicatricial pemphigoid orodynia with minocycline Br J Dermaol 132 1995 784 789
52. Y. Kim, and M.S. Greenberg Management of patients with severe oral mucosal disease Alpha Omegan 94 2001 18 23
53. S.R. Knowles, L. Shapiro, and N.H. Shear Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature Arch Dermatol 132 1996 934 939
54. L. Reiche, F. Wojnarowska, and E. Mallon Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: further support for its efficacy Clin Exp Dermatol 23 1998 254 257
55. D.P. Fivenson, D.L. Breneman, G.B. Rosen, C.S. Hersh, S. Cardone, and D. Mutasim Nicotinamide and tetracycline therapy of bullous pemphigoid Arch Dermatol 130 1994 753 758